xaliproden has been researched along with Diaphragmatic Paralysis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abitbol, JL; Corcia, P; Cudkowicz, M; Gordon, PH; Lacomblez, L; Leigh, PN; Meininger, V; Pochigaeva, K | 1 |
1 review(s) available for xaliproden and Diaphragmatic Paralysis
| Article | Year |
|---|---|
Defining survival as an outcome measure in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Endpoint Determination; Humans; Kaplan-Meier Estimate; Naphthalenes; Outcome Assessment, Health Care; Pentoxifylline; Pyridines; Respiration, Artificial; Respiratory Paralysis; Tracheostomy; Vasodilator Agents | 2009 |